Company
Biomark Diagnostics, Inc.
Headquarters: Richmond, BC, Canada
CEO: Mr. Rashid Ahmed Maula Bux B.Sc., MBA
Market Cap
C$20.9 Million
CAD as of Jan. 1, 2024
US$15.8 Million
Biomark Diagnostics, Inc. Categories
Canada Healthcare Diagnostics & ResearchCanada Healthcare Canada Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $207.62 B |
| Danaher | $171.89 B |
| Siemens Healthineers AG | $66.05 B |
| DexCom, Inc. | $46.50 B |
| IDEXX Laboratories, Inc. | $44.72 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Biomark Diagnostics, Inc. has the following listings and related stock indices.
Stock: CSE: BUX wb_incandescent
Stock: OTC: BMKDF wb_incandescent